Diabetes mellitus

Toujeo Max SoloStar Gets FDA Approval for Patients With Diabetes

By March 27, 2018

Sanofi announced that the Food and Drug Administration (FDA) has approved Toujeo (insulin glargine 300 Units/mL) Max SoloStar, a long-acting insulin pen that holds 900 Units of Toujeo and provides up to 160 Units/mL per injection.

Dapagliflozin Evaluated in Patients With T2D and Moderate Renal Impairment

By March 20, 2018

Farxiga is a sodium-glucose co-transporter 2 (SGLT2) inhibitor currently indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D mellitus.

Three New Type 2 Diabetes Treatments Get FDA Approval

By December 26, 2017

Steglatro, Steglujan, and Segluromet have all received FDA approval for the treatment of type 2 diabetes.

Humalog Junior KwikPen Soon to Be Available

By September 19, 2017

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen.